Integra Lifesciences Holdings (IART) Net Equity Issued and Repurchased (2011 - 2018)
Integra Lifesciences Holdings (IART) reported Net Equity Issued and Repurchased of -$9000.0 for Q3 2018, up 95.89% sequentially from -$219000.0 in Q4 2015.
Integra Lifesciences Holdings (IART) Net Equity Issued and Repurchased (2011 - 2018) Analysis & Trends
Integra Lifesciences Holdings (IART) has 3 years of Net Equity Issued and Repurchased data on file, last reported at -$9000.0 in Q3 2018.
- For the quarter ending Q3 2018, Net Equity Issued and Repurchased changed N/A year-over-year to -$9000.0; the trailing twelve-month figure through Dec 2019 stood at -$9000.0 (changed 0.0% YoY), and the FY2018 full-year result was $349.6 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to -$9000.0 in Q3 2018, from -$219000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of -$9000.0 in Q3 2018 to a low of -$219000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 12.70 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Integra Lifesciences Holdings | 1.50 Bn | 1.23 Bn | 216.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -9,000.00 |
| Sep 30, 2018 | -9,000.00 |
| Dec 31, 2015 | -219,000.00 |
| Dec 31, 2015 | -219,000.00 |
| Dec 31, 2011 | -43.17 Mn |
| Dec 31, 2011 | -43.17 Mn |